ReviewMaterials today. Bio2025
Reconstructing the female reproductive system using 3D bioprinting in tissue engineering.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Exploring endometriosis through 3DMaterials today. Bio · 2026Review
- Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.International journal of pharmaceutics: X · 2026Review
- AI-driven text mining of the female reproductive system: enabling multiscale biomedical modeling and personalized medicine.Nano convergence · 2026Review
- From Preservation to Creation: The Expanding Frontier of Fertility Preservation - Proceedings of the 2Facts, views & vision in ObGyn · 2026Article
- From Production to the Clinic: Decellularized Extracellular Matrix as a Biomaterial for Tissue Engineering and Regenerative Medicine.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three-dimensional bioprinting enables the precise fabrication of complex biological tissues through the layer-by-layer deposition of living cells and biomaterials, offering a promising strategy for reconstructing the female reproductive system. This technology has facilitated the development of in vitro models for tissues such as the endometrium, ovary, cervix, and vagina, providing improved structural fidelity and functional relevance. By leveraging bioinks, including decellularized extracellular matrix and advanced bioprinting techniques, researchers can recreate the intricate microarchitectures and vascular networks required for tissue functionality. These bioprinted systems serve as high-fidelity microphysiological systems for studying reproductive health, modeling disease progression, and evaluating therapeutic responses. Moreover, the integration of artificial intelligence into bioprinting workflows enhances reproducibility, scalability, and patient-specific customization. This review summarizes recent advances in reproductive tissue bioprinting and highlights its potential to transform regenerative gynecology and personalized reproductive healthcare.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.